BSE - SMEListed
Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited

Company website
Check Allotment StatusWatch Live Market
Goldline Pharmaceutical Limited plans to raise ₹27,00,000 crore via IPO. That includes a fresh infusion of ₹27,00,000 crore and an OFS worth ₹0 crore.
Apply from 12-05-2026 until 14-05-2026. Allotment and tentative listing are scheduled for 15-05-2026 and 19-05-2026. Quick tip: check lot size and valuation before bidding.
Start Date12-05-2026
End Date14-05-2026
Listing Date19-05-2026
Allotment Date15-05-2026
Current Price₹59.75
GMP₹12 (27.91%)
Lot Size3000 Shares
Subscription840.81 Times
Face Value₹10 per share
Listing atBSE
Issue Price₹41 - ₹43
Pre Issue₹69,00,000
Post Issue₹96,00,000
Issue Size₹27,00,000
(aggregating up to 11.61 Cr)
Fresh Issue₹27,00,000
(aggregating up to 11.61 Cr)
Offer For Sale-
Advertisement
The Grey Market Premium (GMP) for Goldline Pharmaceutical Limited is currently around ₹12 (27.91%). This indicates an estimated listing price of approximately ₹53 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
15 May 2026, 17:29
₹43
₹12
₹55 (27.91%)
15 May 2026, 17:01
₹43
₹15
₹58 (34.88%)
07 May 2026, 04:33
₹43
₹12
₹55 (27.91%)

Financials overview In Crores

Here is a quick look at the recent financial performance of Goldline Pharmaceutical Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPIDec-25Mar-25Mar-24
EPS
3.22
4.10
3.01
ROE
21.02
35.83
31.31
ROCE
0
0
0
RONW
0
0
0
PRE IPO(PE)
0
10.47
0
POST IPO(PE)
14.56
0
0

Subscription Details (No. of Shares)

The below shows how many shares were subscribed by each investor category in the Goldline Pharmaceutical Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹2.32
418.46
180.37
FIIs
₹0
109.38
0.00
Others
₹0
309.05
0.00
RETAIL
₹3.87
3410.06
881.15
HNIs 2+
₹0.56
556.67
994.05
HNIs 10+
₹1.12
2231.16
1992.11
Total
₹7.87
6616.35
840.71

Application Wise Breakup (Approx. no of Apps)

CategoryReservedAppliedTimes
QIB
0
85
0.00
NIB
0
33,760
0.00
RETAIL
150
1,32,173
881.15
EMPLOYEES
0
0
0.00
HNIs(10L +)
29
20,429
704.45
HNIs (2-10L)
14
13,331
952.21
Shareholder
0
0
0.00
Total
193
1,65,933
859.76
The IPO reservation for Goldline Pharmaceutical Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
Anchor
27.11%
7,32,000
QIB
20.00%
5,40,000
HNI
14.44%
3,90,000
RETAIL
33.33%
9,00,000
Market Maker
5.11%
1,38,000
TOTAL
100.00%
27,00,000

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
2
6,000
₹2,58,000
0
sHNI
3
9,000
₹3,87,000
0
bHNI
8
24,000
₹10,32,000
0
Below you can find the official contact details of Goldline Pharmaceutical Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 712 2786666
Address: 103, F-1, Leela Apartment, Shilpa HSG Society, Near Saptagiri Nagar, Shanidham, Narendra Nagar, Nagpur, Maharashtra, 440015

IPO Registrar

Name: Bigshare Services Private Limited
Phone: +91-22-6263 8200
Advertisement